NEW YORK (GenomeWeb) – The US Food and Drug Administration today issued a revised guidance recommending universal testing of donated whole blood and blood components for Zika virus in the US and its territories.

The FDA first issued guidance on Feb. 16 recommending that only areas with active Zika virus transmission screen whole blood and blood components for the virus, use pathogen-reduction devices, or halt blood collection and obtain whole blood and blood components from areas of the US without active virus transmission.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.